China's $40k CAR-T; Novartis and Biogen strike deals; ObesityWeek readouts
Plus, news about Amylyx, Jiangsu Hengrui and AstraZeneca. China drastically cuts price of a CAR-T: China is adding a CAR-T therapy to its basic medical insurance drug list, or the NRDL ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
